Brooklyn Hospital Center is a medicare approved dialysis facility center in Brooklyn, New York and it has 6 dialysis stations. It is located in Kings county at 121 Dekalb Avenue, Brooklyn, NY, 11201. You can reach out to the office of Brooklyn Hospital Center at (718) 250-8160. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Brooklyn Hospital Center has the following ownership type - Non-Profit. It was first certified by medicare in March, 1985. The medicare id for this facility is 330056 and it accepts patients under medicare ESRD program.
Name | Brooklyn Hospital Center |
---|---|
Location | 121 Dekalb Avenue, Brooklyn, New York |
No. of Dialysis Stations | 6 |
Medicare ID | 330056 |
Managed By | Independent |
Ownership Type | Non-Profit |
Late Shifts | No |
121 Dekalb Avenue, Brooklyn, New York, 11201 | |
(718) 250-8160 | |
News Archive
Two recent FDA approvals have prompted the National Comprehensive Cancer Network (NCCN) to update the NCCN Clinical Practice Guidelines in Oncology(TM) for Non-Hodgkin's Lymphomas to include ofatumumab (Azerra(TM), GlaxoSmithKline) and romidepsin (Istodax(R), Gloucester Pharmaceuticals) as treatment options for select patients with two types of Non-Hodgkin's Lymphomas.
Fifteen new genetic regions associated with coronary artery disease have been identified by a large, international consortium of scientists - including researchers at the Stanford University School of Medicine - taking a significant step forward in understanding the root causes of this deadly disease. The new research brings the total number of validated genetic links with heart disease discovered through genome-wide association studies to 46.
A study published in the Journal of the Medical Directors Association demonstrated that a partnership between long-term care organizations in two countries working in collaboration with researchers and national health care organizations can generate changes that improve quality of care for residents.
A Wayne State University researcher's innovative use of a new tool may make surgery a more viable option for sufferers of obstructive sleep apnea/hypopnea syndrome.
A team of scientists led by Johns Hopkins cardiologist and biomedical engineer Hiroshi Ashikaga, M.D., Ph.D., has developed a mathematical model to measure and digitally map the beat-sustaining electrical flow between heart cells.
› Verified 3 days ago
NPI Number | 1609800432 |
Doing Business As | The Brooklyn Hospital Center |
Address | 121 Dekalb Ave Brooklyn, New York, 11201 |
Phone Number | (718) 488-3736 |
News Archive
Two recent FDA approvals have prompted the National Comprehensive Cancer Network (NCCN) to update the NCCN Clinical Practice Guidelines in Oncology(TM) for Non-Hodgkin's Lymphomas to include ofatumumab (Azerra(TM), GlaxoSmithKline) and romidepsin (Istodax(R), Gloucester Pharmaceuticals) as treatment options for select patients with two types of Non-Hodgkin's Lymphomas.
Fifteen new genetic regions associated with coronary artery disease have been identified by a large, international consortium of scientists - including researchers at the Stanford University School of Medicine - taking a significant step forward in understanding the root causes of this deadly disease. The new research brings the total number of validated genetic links with heart disease discovered through genome-wide association studies to 46.
A study published in the Journal of the Medical Directors Association demonstrated that a partnership between long-term care organizations in two countries working in collaboration with researchers and national health care organizations can generate changes that improve quality of care for residents.
A Wayne State University researcher's innovative use of a new tool may make surgery a more viable option for sufferers of obstructive sleep apnea/hypopnea syndrome.
A team of scientists led by Johns Hopkins cardiologist and biomedical engineer Hiroshi Ashikaga, M.D., Ph.D., has developed a mathematical model to measure and digitally map the beat-sustaining electrical flow between heart cells.
› Verified 3 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
Adult patients getting regular hemodialysis at the center | 43 |
Adult patient months included in Kt/V greater than or equal to 1.2 | 287 |
Percentage of adult patients getting regular hemodialysis at the center | 95 |
Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
Two recent FDA approvals have prompted the National Comprehensive Cancer Network (NCCN) to update the NCCN Clinical Practice Guidelines in Oncology(TM) for Non-Hodgkin's Lymphomas to include ofatumumab (Azerra(TM), GlaxoSmithKline) and romidepsin (Istodax(R), Gloucester Pharmaceuticals) as treatment options for select patients with two types of Non-Hodgkin's Lymphomas.
Fifteen new genetic regions associated with coronary artery disease have been identified by a large, international consortium of scientists - including researchers at the Stanford University School of Medicine - taking a significant step forward in understanding the root causes of this deadly disease. The new research brings the total number of validated genetic links with heart disease discovered through genome-wide association studies to 46.
A study published in the Journal of the Medical Directors Association demonstrated that a partnership between long-term care organizations in two countries working in collaboration with researchers and national health care organizations can generate changes that improve quality of care for residents.
A Wayne State University researcher's innovative use of a new tool may make surgery a more viable option for sufferers of obstructive sleep apnea/hypopnea syndrome.
A team of scientists led by Johns Hopkins cardiologist and biomedical engineer Hiroshi Ashikaga, M.D., Ph.D., has developed a mathematical model to measure and digitally map the beat-sustaining electrical flow between heart cells.
› Verified 3 days ago
Adult patients getting regular peritoneal dialysis at the center | 18 |
Adult patient months included in Kt/V greater than or equal to 1.7 | 145 |
Percentage of adult patients getting regular peritoneal dialysis at the center | 72 |
Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Two recent FDA approvals have prompted the National Comprehensive Cancer Network (NCCN) to update the NCCN Clinical Practice Guidelines in Oncology(TM) for Non-Hodgkin's Lymphomas to include ofatumumab (Azerra(TM), GlaxoSmithKline) and romidepsin (Istodax(R), Gloucester Pharmaceuticals) as treatment options for select patients with two types of Non-Hodgkin's Lymphomas.
Fifteen new genetic regions associated with coronary artery disease have been identified by a large, international consortium of scientists - including researchers at the Stanford University School of Medicine - taking a significant step forward in understanding the root causes of this deadly disease. The new research brings the total number of validated genetic links with heart disease discovered through genome-wide association studies to 46.
A study published in the Journal of the Medical Directors Association demonstrated that a partnership between long-term care organizations in two countries working in collaboration with researchers and national health care organizations can generate changes that improve quality of care for residents.
A Wayne State University researcher's innovative use of a new tool may make surgery a more viable option for sufferers of obstructive sleep apnea/hypopnea syndrome.
A team of scientists led by Johns Hopkins cardiologist and biomedical engineer Hiroshi Ashikaga, M.D., Ph.D., has developed a mathematical model to measure and digitally map the beat-sustaining electrical flow between heart cells.
› Verified 3 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Brooklyn Hospital Center with elevated calcium levels.
Patients with hypercalcemia | 60 |
Hypercalcemia patient months | 442 |
Hypercalcemia patients with serumcalcium greater than 10.2 mg | 2 |
Patients with Serumphosphor | 74 |
Patients with Serumphosphor less than 3.5 mg/dL | 15 |
Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 26 |
Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 21 |
Patients with Serumphosphor from 5.6 to 7 mg/dL | 21 |
Patients with Serumphosphor greater than 7 mg/dL | 17 |
News Archive
Two recent FDA approvals have prompted the National Comprehensive Cancer Network (NCCN) to update the NCCN Clinical Practice Guidelines in Oncology(TM) for Non-Hodgkin's Lymphomas to include ofatumumab (Azerra(TM), GlaxoSmithKline) and romidepsin (Istodax(R), Gloucester Pharmaceuticals) as treatment options for select patients with two types of Non-Hodgkin's Lymphomas.
Fifteen new genetic regions associated with coronary artery disease have been identified by a large, international consortium of scientists - including researchers at the Stanford University School of Medicine - taking a significant step forward in understanding the root causes of this deadly disease. The new research brings the total number of validated genetic links with heart disease discovered through genome-wide association studies to 46.
A study published in the Journal of the Medical Directors Association demonstrated that a partnership between long-term care organizations in two countries working in collaboration with researchers and national health care organizations can generate changes that improve quality of care for residents.
A Wayne State University researcher's innovative use of a new tool may make surgery a more viable option for sufferers of obstructive sleep apnea/hypopnea syndrome.
A team of scientists led by Johns Hopkins cardiologist and biomedical engineer Hiroshi Ashikaga, M.D., Ph.D., has developed a mathematical model to measure and digitally map the beat-sustaining electrical flow between heart cells.
› Verified 3 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
Patients included in arterial venous fistula and catheter summaries | 20 |
Patient months included in arterial venous fistula and catheter summaries | 122 |
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 77 |
News Archive
Two recent FDA approvals have prompted the National Comprehensive Cancer Network (NCCN) to update the NCCN Clinical Practice Guidelines in Oncology(TM) for Non-Hodgkin's Lymphomas to include ofatumumab (Azerra(TM), GlaxoSmithKline) and romidepsin (Istodax(R), Gloucester Pharmaceuticals) as treatment options for select patients with two types of Non-Hodgkin's Lymphomas.
Fifteen new genetic regions associated with coronary artery disease have been identified by a large, international consortium of scientists - including researchers at the Stanford University School of Medicine - taking a significant step forward in understanding the root causes of this deadly disease. The new research brings the total number of validated genetic links with heart disease discovered through genome-wide association studies to 46.
A study published in the Journal of the Medical Directors Association demonstrated that a partnership between long-term care organizations in two countries working in collaboration with researchers and national health care organizations can generate changes that improve quality of care for residents.
A Wayne State University researcher's innovative use of a new tool may make surgery a more viable option for sufferers of obstructive sleep apnea/hypopnea syndrome.
A team of scientists led by Johns Hopkins cardiologist and biomedical engineer Hiroshi Ashikaga, M.D., Ph.D., has developed a mathematical model to measure and digitally map the beat-sustaining electrical flow between heart cells.
› Verified 3 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
Patients in facility's Hospitalization Summary | 40 |
Hospitalization Rate in facility | 270.3 (As Expected) |
Hospitalization Rate: Upper Confidence Limit | 434 |
Hospitalization Rate: Lower Confidence Limit | 174.7 |
News Archive
Two recent FDA approvals have prompted the National Comprehensive Cancer Network (NCCN) to update the NCCN Clinical Practice Guidelines in Oncology(TM) for Non-Hodgkin's Lymphomas to include ofatumumab (Azerra(TM), GlaxoSmithKline) and romidepsin (Istodax(R), Gloucester Pharmaceuticals) as treatment options for select patients with two types of Non-Hodgkin's Lymphomas.
Fifteen new genetic regions associated with coronary artery disease have been identified by a large, international consortium of scientists - including researchers at the Stanford University School of Medicine - taking a significant step forward in understanding the root causes of this deadly disease. The new research brings the total number of validated genetic links with heart disease discovered through genome-wide association studies to 46.
A study published in the Journal of the Medical Directors Association demonstrated that a partnership between long-term care organizations in two countries working in collaboration with researchers and national health care organizations can generate changes that improve quality of care for residents.
A Wayne State University researcher's innovative use of a new tool may make surgery a more viable option for sufferers of obstructive sleep apnea/hypopnea syndrome.
A team of scientists led by Johns Hopkins cardiologist and biomedical engineer Hiroshi Ashikaga, M.D., Ph.D., has developed a mathematical model to measure and digitally map the beat-sustaining electrical flow between heart cells.
› Verified 3 days ago
The rate of readmission show you whether patients who were being treated regularly at Brooklyn Hospital Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
Readmission Rate in facility | 30.1 (As Expected) |
Readmission Rate: Upper Confidence Limit | 41.8 |
Readmission Rate: Lower Confidence Limit | 20 |
News Archive
Two recent FDA approvals have prompted the National Comprehensive Cancer Network (NCCN) to update the NCCN Clinical Practice Guidelines in Oncology(TM) for Non-Hodgkin's Lymphomas to include ofatumumab (Azerra(TM), GlaxoSmithKline) and romidepsin (Istodax(R), Gloucester Pharmaceuticals) as treatment options for select patients with two types of Non-Hodgkin's Lymphomas.
Fifteen new genetic regions associated with coronary artery disease have been identified by a large, international consortium of scientists - including researchers at the Stanford University School of Medicine - taking a significant step forward in understanding the root causes of this deadly disease. The new research brings the total number of validated genetic links with heart disease discovered through genome-wide association studies to 46.
A study published in the Journal of the Medical Directors Association demonstrated that a partnership between long-term care organizations in two countries working in collaboration with researchers and national health care organizations can generate changes that improve quality of care for residents.
A Wayne State University researcher's innovative use of a new tool may make surgery a more viable option for sufferers of obstructive sleep apnea/hypopnea syndrome.
A team of scientists led by Johns Hopkins cardiologist and biomedical engineer Hiroshi Ashikaga, M.D., Ph.D., has developed a mathematical model to measure and digitally map the beat-sustaining electrical flow between heart cells.
› Verified 3 days ago